חזרה לתוצאות החיפוש

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Acute Lymphoblastic Leukemia · Relapsed Pediatric ALL · Refractory Acute Lymphoblastic Leukemia

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Beijing Children's Hospital.Capital Medical University, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Tianyou Wang, M.D)
    M.D
    Contact: Principal Investigator (Tianyou Wang, M.D)
    Ruidong Zhang, M.D (Sub-investigator)

  • Beijing GoBroad Boren Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Jin Pan, M.D)
    Contact: Principal Investigator (Jin Pan, M.D)

  • Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Qun Hu, M.D)
    Contact: Principal Investigator (Qun Hu, M.D)
    Aiguo Liu, M.D (Sub-investigator)
    Yaqin Wang, M.D (Sub-investigator)
    Ai Zhang, M.D (Sub-investigator)

  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Yicheng Zhang, M.D)
    Contact: Principal Investigator (Yicheng Zhang, M.D)
    Zhenya Hong, M.D (Sub-investigator)
    Di Wang, M.D (Sub-investigator)
    Yang Cao, M.D (Sub-investigator)

  • Xiehe Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Runming Jin, M.D)
    Contact: Principal Investigator (Runming Jin, M.D)
    Xiaoyan Wu, M.D (Sub-investigator)

  • The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

    Contact: Study coordinator (Hongling Peng, M.D)
    Contact: Principal Investigator (Hongling Peng, M.D)
    Yajuan Cui, M.D (Sub-investigator)
    Ruijuan Li, M.D (Sub-investigator)

  • Children's Hospital Of Soochow University, Suzhou, Jiangsu, China

    Contact: Study coordinator (Shaoyan Hu, M.D)
    Contact: Principal Investigator (Shaoyan Hu, M.D)

  • The First Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Fei Li, M.D)
    Contact: Principal Investigator (Fei Li, M.D)
    Min Yu, M.D (Sub-investigator)
    Fancong Kong, M.D (Sub-investigator)

  • West China Second University Hospital,Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Ju Gao, M.D)
    Contact: Principal Investigator (Ju Gao, M.D)

  • Institute Of Hematology&Blood Diseases Hospital,Chinese Academy Of Medicai Sciences, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Xiaofan Zhu, M.D)
    Contact: Principal Investigator (Xiaofan Zhu, M.D)
    Yumei Chen, M.D (Sub-investigator)
מובילי המחקר

  • Tianyou Wang, M.D. Ph.D

    Principal Investigator

    Beijing Children's Hospital

  • Yicheng Zhang, M.D. Ph.D

    Principal Investigator

    Tongji Hospital

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)